Market Forecast by Countries (China, India, Japan, Australia, Indonesia, Philippines, Thailand, Malaysia, Rest of Asia), By Study Design (Interventional, Expanded Access, Observational), By Indication (Cardiovascular, Oncology, Others) And Competitive Landscape
Product Code: ETC076133 | Publication Date: Aug 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
Asia Pacific Virtual Clinical Trials Market is expected to witness growth in the coming years. In Asia Pacific, benefits of Virtual Clinical trial models including cost efficiency, convenience for the patient, data accuracy, and larger geographic reach. The growing rate of neurological diseases are tumours, depression, epilepsy, Parkinson's, and Alzheimer's combined with the increasing geriatric population are anticipated to boost the growth of the virtual clinical trial market over the period. Growing clinical trials to find reliable and effective solutions to cure the spread of neurological disorders and age-related diseases are components that will boost the growth of the virtual clinical trials market. Additionally, the instance of tropical and infectious diseases that need new medicines and drugs in numerous countries is a component anticipated to boost the growth of the virtual clinical trial market during the forecast period. Moreover, the modernization of clinical trials to improve productivity and collect information from many sources is a component anticipated to propel the growth of the clinical trial market in the next few years. The Oncology segment is expected to lead the market. The virtual trial model does not work well for trials that require a lot of office visits or complex procedures. Trials that require radiographic procedures, surgical procedures such as biopsies, or complex investigational product administration and these procedures cannot be done at a patient’s home and require a specialist to complete. It is also operationally challenging to have all procedures done virtually. Data security is another potential challenge. Large amounts of patients’ personal data are transmitted via the Internet. They need to ensure patients are aware of the risk of data breaches in the informed consent form. COVID-19 is making virtual and decentralized approaches to clinical trials necessary. The pandemic has led to an upsurge to the virtual clinical trials and current scenario is forcing the clinical trial industry to change the way of their ongoing and upcoming trials.
According the 6Wresearch, the Asia Pacific Virtual Clinical Trials Market is likely to witness significant growth during 2021-2027. In India, virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials and providing access to diverse patient populations. Australia has developed a Clinical Trial Notification (CTN) scheme which offers a straight forward, efficient, and reliable regulatory process. Further, China is also investing in improving its regulatory environment, leading to reductions in start-up time. Several countries have introduced or expanded universal health coverage, including Thailand, Vietnam, China, and Singapore. Private insurance coverage has also increased in the last few years. Japan, China, Singapore are front-runners in stem cell therapy due to market-friendly government regulations and significant funding. Japan has a conditional marketing approval option for regenerative medicines, which allows companies to sell the drug earlier in the clinical research, expanding their revenue cycle. The Asia Pacific region is also home to renowned centres of excellence for oncology and paediatrics, including Samsung Comprehensive Cancer Centre at the Samsung Medical Centre (Korea), Peter MacCullum Cancer Centre (Australia), and Royal Children’s Hospital (Australia). The fast-growing middle-class in the region with its disposable income will drive the pharma market. Asia has large, state-of-the-art clinical trial centres that meet patient enrolment and retention goals and generate high-quality data, and are led by skilled investigators. As transparency in the regulatory environment improves, Asia is poised to become the preferred destination for clinical trials.
The Key players profiled in Virtual clinical trials are Covance Inc, Oracle corporation, IQVIA holdings. Asia Pacific’s largest expertized biotech CRO “Novotech” the company is observing an increase in demand from biotechnology sponsor for studies in the Asia Pacific region due to the availability of quality and speed. An increasing number of biotechnology firms are looking at the Asia Pacific region for the Covid19 trials to take advantage of the large patient pool and fast track procedures.
The Asia-Pacific Virtual Clinical Trials Market report thoroughly covers the market by study, by indications and key countries including India, China, Japan, Australia, Indonesia and rest of Asia Pacific. The Asia-Pacific Virtual Clinical Trials market outlook report provides an unbiased and detailed analysis of the on-going Asia-Pacific market trends, high growth areas and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Markets Covered
The Market Report covers the following segment:
Other Key Reports Available:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Asia Pacific Virtual Clinical Trials Market Overview |
3.1 Asia Pacific Regional Macro Economic Indicators |
3.2 Asia Pacific Virtual Clinical Trials Market Revenues & Volume, 2020 & 2027F |
3.3 Asia Pacific Virtual Clinical Trials Market - Industry Life Cycle |
3.4 Asia Pacific Virtual Clinical Trials Market - Porter's Five Forces |
3.5 Asia Pacific Virtual Clinical Trials Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Asia Pacific Virtual Clinical Trials Market Revenues & Volume Share, By Study Design, 2020 & 2027F |
3.7 Asia Pacific Virtual Clinical Trials Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Asia Pacific Virtual Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Asia Pacific Virtual Clinical Trials Market Trends |
6 Asia Pacific Virtual Clinical Trials Market, 2017 - 2027 |
6.1 Asia Pacific Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
6.2 Asia Pacific Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
7 China Virtual Clinical Trials Market, 2017 - 2027 |
7.1 China Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
7.2 China Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
8 India Virtual Clinical Trials Market, 2017 - 2027 |
8.1 India Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
8.2 India Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
9 Japan Virtual Clinical Trials Market, 2017 - 2027 |
9.1 Japan Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
9.2 Japan Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
10 Australia Virtual Clinical Trials Market, 2017 - 2027 |
10.1 Australia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
10.2 Australia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
11 Indonesia Virtual Clinical Trials Market, 2017 - 2027 |
11.1 Indonesia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
11.2 Indonesia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
12 Philippines Virtual Clinical Trials Market, 2017 - 2027 |
12.1 Philippines Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
12.2 Philippines Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
13 Malaysia Virtual Clinical Trials Market, 2017 - 2027 |
13.1 Malaysia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
13.2 Malaysia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
14 Rest of Asia Virtual Clinical Trials Market, 2017 - 2027 |
14.1 Rest of Asia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
14.2 Rest of Asia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
11 Asia Pacific Virtual Clinical Trials Market Key Performance Indicators |
12 Asia Pacific Virtual Clinical Trials Market - Opportunity Assessment |
12.1 Asia Pacific Virtual Clinical Trials Market Opportunity Assessment, By Countries, 2020 & 2027F |
12.2 Asia Pacific Virtual Clinical Trials Market Opportunity Assessment, By Study Design, 2020 & 2027F |
12.3 Asia Pacific Virtual Clinical Trials Market Opportunity Assessment, By Indication, 2020 & 2027F |
13 Asia Pacific Virtual Clinical Trials Market - Competitive Landscape |
13.1 Asia Pacific Virtual Clinical Trials Market Revenue Share, By Companies, 2020 |
13.2 Asia Pacific Virtual Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
14 Company Profiles |
15 Recommendations |
16 Disclaimer |